|
The
computation of net loss per share for the three months ended March 31, 2026 and 2025 was as follows:
Schedule of Net Loss Per Share Basic and Diluted
| |
|
2026 |
|
|
2025 |
|
| |
|
Three months ended March 31,
|
|
| |
|
2026 |
|
|
2025 |
|
| Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
| Net loss available to common stockholders |
|
$ |
(3,377,179 |
) |
|
$ |
(2,834,405 |
) |
| Weighted average number of common shares-basic and diluted |
|
|
2,623,143 |
|
|
|
373,967 |
|
| |
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share |
|
$ |
(1.29 |
) |
|
$ |
(7.58 |
) |
| |
|
2026 |
|
|
2025 |
|
| Weighted-average number of common shares outstanding – basic and diluted |
|
|
2,572,114 |
|
|
|
176,223 |
|
| Pre-Funded Warrants considered issued for EPS purposes |
|
|
- |
|
|
|
190,312 |
|
| Weighted-average number of vested RSUs– basic and diluted |
|
|
51,029 |
|
|
|
7,432 |
|
| Weighted-average number of common shares-basic and diluted |
|
|
2,623,143 |
|
|
|
373,967 |
|
|